Company
Risk-Tolerant Investors Should Take A Chance On Karyopharm Therapeutics Inc (NASDAQ: KPTI)
During the last session, Karyopharm Therapeutics Inc (NASDAQ:KPTI)’s traded shares were 77987.0, with the beta value of the company hitting 0.32. At the end of
